Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma

Pancreatic cancer remains one of the most lethal malignancies worldwide. The combination of the first-line standard agent gemcitabine (GEM) with the molecular-targeted drug erlotinib (Er) has emerged as a promising strategy for pancreatic cancer treatment. However, the clinical benefit from this com...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Honglin, Xue, Yanan, Li, Bowen, Xu, Xiaojie, Zhang, Fu, Guo, Jiajing, Li, Qijun, Yuan, Tingting, Chen, Yuan, Pan, Yubin, Ping, Yuan, Li, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366227/
https://www.ncbi.nlm.nih.gov/pubmed/35967289
http://dx.doi.org/10.1016/j.apsb.2022.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366227/
https://www.ncbi.nlm.nih.gov/pubmed/35967289
http://dx.doi.org/10.1016/j.apsb.2022.02.007

Ejemplares similares